Registered entities
Pathway Therapeutics
Reg. No. 01-0972928United States
Investor mix
3 investors on record; lead investors include GBS, Talu Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Develops isoform specific inhibitors for oncology and inflammation
3 investors on record; lead investors include GBS, Talu Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |